Celldex Therapeutics
CLDX
#4532
Rank
C$2.50 B
Marketcap
$37.70
Share price
3.05%
Change (1 day)
1.30%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.24

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.35. In 2022 the company made an earnings per share (EPS) of -$3.34 a decrease over its 2021 EPS that were of -$2.29.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.24-2.9%
2022-$3.3445.73%
2021-$2.29-23.36%
2020-$2.99-41.05%
2019-$5.07-76.95%
2018-$21.9845.03%
2017-$15.16-42.54%
2016-$26.38-3.82%
2015-$27.43-0.76%
2014-$27.6329.41%
2013-$21.350%
2012-$21.35-9.73%
2011-$23.661312.5%
2010-$1.67-95.79%
2009-$39.75-49.64%
2008-$78.93-82.64%
2007-$454.72-44.98%
2006-$826.531270.83%
2005-$60.2933.33%
2004-$45.22-10%
2003-$50.24-16.67%
2002-$60.29-38.46%
2001-$97.98-4.88%
2000-$103.00-81.66%
1999-$561.48-87.2%
1998-$4,385206.39%
1997-$1,43113.02%
1996-$1,266

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.60 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.19-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.86 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.75-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.60-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.89-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.80-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA